Health · August 20, 2026 · 6 min read

GHK-Cu: the copper peptide with 50 years of research behind it

Copper peptides are having a moment in skincare, but GHK-Cu has been studied since 1973. Here is what the clinical evidence actually shows.

Copper peptides show up on serum labels next to retinol and niacinamide, usually listed as copper tripeptide-1. Unlike most ingredients that trend and fade, GHK-Cu has been under continuous scientific study since 1973, and a meaningful part of that research is human clinical work rather than cell-culture data alone.

A molecule your body already makes

GHK-Cu is glycyl-L-histidyl-L-lysine bound to a copper ion — a tripeptide found naturally in human plasma, saliva, and urine. It was first isolated from plasma by researcher Loren Pickart in 1973, in work that showed plasma from younger donors could make older cells behave more like young ones. GHK-Cu turned out to be the active component.

The body releases it as part of the wound-response system: after tissue injury, plasma levels rise quickly and repair follows — cells migrate to the site, new collagen forms, and fresh blood vessels grow in. Circulating GHK-Cu declines with age, which parallels what we see in aging skin: a thinner dermis, slower healing, and less collagen turnover. Topical use is essentially reapplying that repair signal where you want it.

How it works in skin

Copper is a cofactor in building strong collagen; without enough available copper, collagen still forms but is structurally weaker. GHK-Cu also engages tissue-remodeling signaling pathways, and gene-expression work has reported that it can shift the activity of roughly a third of human genes toward a more youthful pattern. In laboratory studies, skin cells exposed to GHK-Cu produce more collagen, more elastin, and more of the moisture-binding glycosaminoglycans — precisely the three things aging skin loses.

What the clinical trials report

Wrinkles. In a comparison against a leading synthetic peptide, GHK-Cu was reported to reduce wrinkle volume by about 55.8% and wrinkle depth by about 32.8% versus untreated control, outperforming the comparator. A separate 12-week trial in 71 women found significant improvement in fine-line depth and firmness, measured by cutometry and ultrasound imaging.

Structural collagen. A randomized controlled trial in photoaged skin found measurable improvement in fine wrinkles, pigmentation, and roughness. A three-month ultrasound study of 21 participants reported an average 28% increase in collagen density, with the top quartile above 50% — change beneath the surface rather than temporary plumping.

Versus retinol. Only one study has compared them head to head. In it, a topical copper-peptide cream outperformed prescription tretinoin on collagen production, with 70% of copper-peptide users showing increased procollagen synthesis — and it was generally better tolerated. Many practices use the two together rather than as substitutes.

Why this matters for a protocol-based practice

Skepticism is a reasonable default in skincare. GHK-Cu is an exception because the evidence base is longer and more consistent than nearly anything else in the category — and on the medical-grade side, it is eligible for pharmacy compounding, which means a clinician-supervised formulation rather than an over-the-counter guess at concentration.

Rise Wellness and Longevity protocols are prescribed by licensed clinicians and dispensed exclusively by licensed 503A and 503B pharmacies, with clinical infrastructure by Altro Health.

Sources

Adapted for Rise Wellness and Longevity from reporting originally published by Altro Health. Educational content only; not medical advice.

Find your protocol All articles